Lebwohl David's Form 4/A amendment
AmendedIntellia Therapeutics, Inc. (NTLA) · filed Mar 4, 2022
- Accession no.
- 0001209191-22-016533
- Filed
- Mar 4, 2022
- Trade date
- Mar 1, 2022
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Mar 3, 2022
This filing lists 1 derivative transaction. It carries over 4 transactions from the original filing that it did not restate. Open-market sales total $118.0K. It was filed 3 days after the trade.
This amendment restates part of 0001209191-22-015960 (filed Mar 3, 2022). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lebwohl DavidCIK 0001810882 | Officer (EVP, Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2022 | Common Stock | AGrant or awardAcquired | +20,203 | $0.00 | $0 | 20,203 | Direct |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001209191-22-015960 (filed Mar 3, 2022).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 1, 2022 | Common Stock | MOption exerciseAcquired | +3,187 | – | – | 11,973 | Direct | |
| Jan 1, 2022 | Common Stock | SSaleDisposed | −1,051 | $112.24 | −$117,964.24 | 10,922 | Direct | |
| Mar 1, 2022 | Common Stock | AGrant or awardAcquired | +13,816 | $0.00 | $0 | 24,738 | Direct |
Derivative securities (Table II)
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 1, 2022 | Common Stock | MOption exerciseDisposed | −3,187 | $0.00 | $0 | 9,563 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.